转自：新华财经 新华财经北京11月14日电 四大证券报内容精华摘要如下： 中国证券报 •前10个月人民币贷款增加近15万亿元 金融总量合理增长 货币政策保持力度 中国人民银行11月13日发布的10月金融数据显示，广义货币（M2）和社会融资规模同比增速均保持在 较高水平，持续为经济回升向好创造适宜的货币金融环境；贷款规模保持合理增长，信贷结构持续优 化。专家表示，未来央行将继续实施好适度宽松的货币政策，把握好力度和节奏，保持对实体经济较强 支持力度。 11月13日，A股市场低开高走，放量上涨，成交额为2.07万亿元，上证指数盘中站上4030点，创逾十年 新高，深证成指涨逾1%，创业板指涨逾2%。市场表现分化，锂电产业链全线上涨，锂电电解液、锂 矿、锂电正极、锂电负极、锂电池等板块爆发，整个A股市场超3900只股票上涨，逾100只股票涨停。 截至11月13日，A股总市值为119.90万亿元，创历史新高。11月13日沪深两市主力资金净流入超120亿 元，结束连续13个交易日的净流出，资金情绪转为乐观。分析人士认为，短期市场处于政策和业绩空窗 期，指数向上突破关键点位尚需更多催化，市场或仍以震荡为主。 近期，受产业链 ...

（一） 中国的发展离不开世界，世界的繁荣也需要中国。开放合作、互利共赢，是解码中国式现代化的一把钥 匙。 11月10日，第八届进博会在上海闭幕。习近平总书记亲自谋划的世界上第一个以进口为主题的国家级展 会，是国际贸易发展史上的一大创举。本届834.9亿美元的按年计意向成交额、138个国家和地区的4108 家企业参展的成绩，均刷新历史纪录。 11月6日，习近平总书记在海南指出："党中央决定，今年12月18日海南自由贸易港正式启动全岛封关， 这是我国坚定不移扩大高水平对外开放、推动建设开放型世界经济的标志性举措。" 以全面深化改革开放推动高质量发展，集中力量办好自己的事，通过高水平对外开放为世界注入确定性 与稳定性，是习近平新时代中国特色社会主义思想的重要内容。 今天，再次学习领会习近平总书记2018年在首届进博会开幕式上的主旨演讲《共建创新包容的开放型世 界经济》，更加深刻感悟到思想的力量。 "举办中国国际进口博览会，是中国着眼于推动新一轮高水平对外开放作出的重大决策，是中国主动向 世界开放市场的重大举措。" "中国将抓紧研究提出海南分步骤、分阶段建设自由贸易港政策和制度体系，加快探索建设中国特色自 由贸易港进 ...

Core Viewpoint - The 14th meeting of the China-Ireland Economic and Trade Joint Committee highlighted the strengthening of the strategic partnership between China and Ireland, emphasizing mutual benefits in trade and investment, and the commitment to free trade and multilateral trade systems [1] Group 1: Economic Cooperation - The meeting was co-hosted by China's Vice Minister of Commerce and Ireland's Minister for Enterprise, Trade and Employment, indicating high-level engagement between the two countries [1] - Both countries support the development of a balanced bilateral trade relationship, with China being Ireland's largest trading partner in Asia [1] Group 2: Areas of Collaboration - China is willing to enhance strategic alignment with Ireland, focusing on cooperation in digital economy, green energy, biomedicine, technological innovation, and financial services [1] - The "14th Five-Year Plan" period will see China expanding its service sector, providing ample opportunities for Irish enterprises to invest in China [1] Group 3: Global Economic Impact - The economic development of China is seen as a source of certainty for global economic growth, reinforcing the importance of the China-Ireland trade relationship [1] - Ireland's open and free economy is positioned to welcome Chinese enterprises and financial institutions for investment and joint research and development, facilitating integration into the global value chain [1]

来源：新浪证券-红岸工作室 11月13日，ST诺泰涨0.23%，成交额2.23亿元，换手率1.74%，总市值126.71亿元。 4、公司磷酸奥司他韦胶囊获批 药品批准文号：国药准字H20223349 药品批准文号有效期：至2027年05 月30日 磷酸奥司他韦胶囊为一款抗流感病毒药物，主要用于成人和1岁及1岁以上儿童的甲型和乙型流 感治疗，以及用于成人和13岁及13岁以上青少年的甲型和乙型流感的预防。 5、根据2024年年报，公司海外营收占比为63.12%，受益于人民币贬值。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入2169.99万，占比0.1%，行业排名24/159，连续3日被主力资金增仓；所属行业主力净流 入5.01亿，连续2日被主力资金增仓。 区间今日近3日近5日近10日近20日主力净流入2169.99万7366.05万4830.09万1669.74万-5594.47万 异动分析 CRO概念+减肥药+肝炎概念+流感+人民币贬值受益 1、公司的定制类产品业务主要是CDMO业务,CDMO(合同研发与生产组织)更强调生产工艺的研发和技 术创新能 ...

"杭州在生物医药和人工智能两个领域都有非常强的产业布局，有充沛的人才储备，这样的交叉优 势在全国绝无仅有。"南加州大学分子学博士李逸石带来的司南智药项目，可以通过AI大模型深度分析 全球生物医药数据，精准挖掘早期药物资产潜力，定向孵化满足药企未来3-5年需求的产品。 来自伊利诺伊大学香槟分校的圆炬科技团队，更想在杭州找到应用场景和耐心资本。"我们的技术 就像'微观世界的机器人抓手'，通过激光精准控制高分子材料，能轻松转移LED微芯片、光电子器件， 能应用在下一代显示器和硅基光芯片领域。"圆炬科技CEO张顺介绍，团队面向显示领域的项目在绍兴 设有初创公司，但基于硅基光电子和新型可穿戴电子的项目有意向落地杭州，"杭州在这一领域的产业 集聚度、人才吸引力和投融资环境更活跃，而且像光子嫩肤医美、脑机接口等应用场景非常丰富，能帮 我们快速打开市场，实现技术商业化落地。" 自2006年以来，海外英才杭州项目对接会已连续举办20届，吸引近1100位海外高层次科技人才，携 1200多个项目来杭对接，签约金额突破1.55亿元，近3年项目落地转化率高达17.3%，已成为杭州链接全 球创新资源的重要平台。 杭州市科学技术协会党组书 ...

Core Viewpoint - Kangchen Pharmaceutical's stock has shown significant growth this year, with a year-to-date increase of 105.40%, despite recent fluctuations in the short term [2]. Financial Performance - For the period from January to September 2025, Kangchen Pharmaceutical achieved a revenue of 6.92 billion yuan, representing a year-on-year growth of 7.10%. The net profit attributable to the parent company was 1.28 billion yuan, reflecting a year-on-year increase of 13.19% [2]. - The company has distributed a total of 4.37 billion yuan in dividends since its A-share listing, with 1.75 billion yuan distributed over the past three years [3]. Stock Market Activity - As of November 13, Kangchen Pharmaceutical's stock price was 47.08 yuan per share, with a market capitalization of 75.03 billion yuan. The stock experienced a 2.06% increase during the trading session [1]. - The stock has been active on the龙虎榜 (top trading list) four times this year, with the most recent appearance on September 1 [2]. Shareholder Structure - As of September 30, 2025, the number of shareholders increased to 10,700, up by 7.18% from the previous period. The average number of circulating shares per shareholder decreased by 6.12% to 14,806 shares [2]. - New institutional shareholders include several funds, such as Qianhai Kaiyuan and Huatai-PineBridge, which have recently entered the top ten circulating shareholders list [3].

Core Viewpoint - Kanghong Pharmaceutical's stock has shown significant volatility, with a year-to-date increase of 70.47%, but recent trends indicate a decline over the past 20 and 60 days [1][2]. Financial Performance - For the period from January to September 2025, Kanghong Pharmaceutical reported a revenue of 3.624 billion yuan, representing a year-on-year growth of 6.23%, and a net profit attributable to shareholders of 1.033 billion yuan, with a growth of 6.08% [2]. - The company has distributed a total of 2.038 billion yuan in dividends since its A-share listing, with 1.04 billion yuan distributed over the past three years [3]. Shareholder Information - As of October 20, 2025, the number of shareholders for Kanghong Pharmaceutical increased by 3.53% to 24,900, while the average circulating shares per person decreased by 3.41% to 27,592 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 28.007 million shares, an increase of 732,000 shares from the previous period [3]. Stock Market Activity - On November 13, Kanghong Pharmaceutical's stock price rose by 2.08% to 32.39 yuan per share, with a trading volume of 139 million yuan and a turnover rate of 0.63% [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on July 21 [1].

君实生物所属申万行业为：医药生物-生物制品-其他生物制品。所属概念板块包括：抗癌药物、抗癌治 癌、创新药、生物医药、精准医疗等。 截至9月30日，君实生物股东户数3.59万，较上期增加15.17%；人均流通股21361股，较上期减少 12.96%。2025年1月-9月，君实生物实现营业收入18.06亿元，同比增长42.06%；归母净利润-5.96亿元， 同比增长35.72%。 资金流向方面，主力资金净流入842.99万元，特大单买入384.09万元，占比4.73%，卖出119.26万元，占 比1.47%；大单买入1736.34万元，占比21.37%，卖出1158.19万元，占比14.25%。 君实生物今年以来股价涨42.92%，近5个交易日涨1.38%，近20日涨0.46%，近60日跌10.12%。 资料显示，上海君实生物医药科技股份有限公司位于上海市浦东新区平家桥路100弄6号7幢16层,香港铜 锣湾希慎道33号利园1期19楼1918室，成立日期2012年12月27日，上市日期2020年7月15日，公司主营业 务涉及单克隆抗体药物和其他治疗型蛋白药物的研发与产业化,单克隆抗体药物研发的技术服务与技术 转让等 ...

Core Insights - The implementation of four action plans has achieved full coverage of 19 iconic industrial chains in Shandong Province, focusing on technological innovation in key industries [1] Group 1: Robotics Industry - The robotics industry will leverage the strategic opportunity of integrating robotics technology with artificial intelligence, focusing on key components, software systems, and complete machine manufacturing [2] - The plan aims to develop advanced servo motors, operating system software, and special robots, while expanding application scenarios across various sectors such as automotive, home appliances, and healthcare [2] - The goal is to create 100 representative benchmark application scenarios, positioning Shandong as a national hub for robotics technology innovation [2] Group 2: Modern Food Industry - The modern food industry will emphasize safety, nutrition, green, and intelligent development, addressing the entire supply chain from raw materials to processing equipment [2] - A technical system will be established for food safety, including traceability, quality control, and green packaging, enhancing consumer safety and satisfaction [2] - The industry aims to create over 100 innovative products, significantly increasing the added value of modern food [2] Group 3: Light Industry and Textiles - The light industry and textiles sector will focus on high-end, green, and intelligent development, enhancing low-carbon production processes and advanced product development [3] - Innovations will include multifunctional advanced fiber products and high-end medical textiles, as well as new paper products for specialized applications [3] Group 4: Modern Metallurgy Industry - The modern metallurgy industry will accelerate the development of high-end raw materials and precision processing technologies, targeting products like ultra-high-strength steel and marine aluminum alloys [3] - The focus will also be on developing frontier materials such as rare earth functional materials and special magnesium and titanium alloys to capture future industry opportunities [3] Group 5: Implementation Measures - The four action plans propose specific measures for promoting innovation resources, building innovation platforms, and ensuring the transformation of scientific achievements [3] - The provincial science and technology department will implement policies to inject new momentum into the construction of a modern industrial system [4]

Core Insights - The 2025 Shanghai Stock Exchange International Investor Conference opened on November 12, focusing on "Value Leadership, Open Empowerment - New Opportunities for International Capital Investment and Mergers" [1] - The conference attracted over 100 renowned investment institutions and nearly 400 representatives from regions including Europe, America, Asia-Pacific, and the Middle East, discussing new opportunities in Chinese investment and mergers, technology innovation, and high-level capital market openness [1][2] - Global asset management leaders expressed optimism about the long-term investment value in China, citing a stable macroeconomic environment, improved policy conditions, and accelerated technological innovation [1][2] Market Developments - China's capital market is steadily expanding its institutional openness, with ongoing optimization of the Qualified Foreign Institutional Investor (QFII) system, which has received high recognition for its stability, transparency, and predictability [2] - The Shanghai Stock Exchange and Singapore Exchange launched the China Securities Index Singapore Exchange Asia 100 Index series during the conference, marking a significant step in international cooperation [2] - The conference highlighted the achievements of the Shanghai Stock Exchange in supporting technological innovation and the development of new productive forces, particularly in the context of the seventh anniversary of the Sci-Tech Innovation Board [2] Future Outlook - The Shanghai Stock Exchange aims to enhance market inclusivity and adaptability while improving its attractiveness and competitiveness in response to complex internal and external changes in the capital market [3] - The exchange plans to leverage favorable opportunities for open cooperation to promote the long-term and stable development of the capital market in collaboration with global investors [3]